An A1cNOW+ is a single-use, disposable, and reimbursable point-of-care fingerstick blood test that measures diabetes (Prediabetes, Diabetes, and Gestational) in 5-minutes from an average blood glucose level over the past 3-months. 

The relationship of individual comorbid chronic conditions to diabetes has reflected that obesity is related to a lack of A1c and BP control and of seventeen (17) conditions related to achieving control goals, sixteen (16) were related to achieving A1c control. It is vital to regularly check the A1c for comorbid chronic conditions that are seen and unseen.

NEW HEDIS Measures

NEW HEDIS Measures for Comprehensive Diabetes Care (CDC) added the HbA1c test to determine the Control <8% and Poor Control >9% indicator. Comprehensive Diabetes Care/Hemoglobin A1c Control for Patients With Diabetes, Eye Exam Performed for Patients With Diabetes, Blood Pressure for Patients With Diabetes. NCQA separated the indications into three (3 ) standalone measures:

The A1CNow®+ system provides healthcare professionals with a fast and easy way of obtaining accurate A1C results with just a fingerstick. This innovative technology enables clinicians to communicate face-to-face with patients about their diabetes control in minutes, not days.

Use our Afterpay when checking out for four (4) interest-free installments as low as $50.00.

 Reimbursement for A1C Testing

Step 1: Submit an application to apply for a CLIA Certificate of Waiver

The first step in receiving any Medicare reimbursement is to obtain a CLIA Certificate of Waiver. The physician’s office or laboratory will need to pay a fee to the Centers for Medicare and Medicaid Services (CMS) every two years and agree to follow the device manufacturer’s instructions for performing clinical tests.

Step 2: Submit the Appropriate CPT Codes

The following Current Procedural Terminology (CPT) codes are suggested for submitting tests performed with PTS Diagnostics products for Medicare and Medicaid reimbursement. These are suggested codes.

83036 QW — For professional use in the management of diabetes mellitus where regular determinations of blood glucose levels are required.  Glycated hemoglobin assesses glycemic control over a period of approximately 120 days ($13 average)

36416 — Collection of capillary blood (Fingerstick) specimen ($3 average)

A Value-Based Resource

Simply Better